Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9128)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2018 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Wang M, Zhang B, Wu X, Lin TL, Liu XF, Zhou Y, Zhang XH, Xu H, Shen LJ, Zou J, Lu P, Zhang D, Gu WJ, Zhang MX, Pan J, Cao H, Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors. World J Gastroenterol 2018; 24(46): 5189-5202 [PMID: 30581268 DOI: 10.3748/wjg.v24.i46.5189] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i46/5189.htm |
| Number | Citing Articles |
| 1 |
Xuehui Jiang, Qun Fu, Ying Kong, Hong Liu, Kaisaner Rexiti, Hongwei Peng, Pin Xiao, Xiaohua Wei. Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor. Pharmacogenomics 2023; 24(7): 425 doi: 10.2217/pgs-2022-0171
|
| 2 |
Xiao Huang, Linhua Chen, Li Liu, Hefen Chen, Zhujun Gong, Jianbo Lyu, Yao Li, Qi Jiang, Xiangyu Zeng, Peng Zhang, Hong Zhou. Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor. International Immunopharmacology 2024; 140: 112728 doi: 10.1016/j.intimp.2024.112728
|
| 3 |
Ryo Fujiwara, Takeshi yuasa, kenichi kobayashi, tetsuya yoshida, susumu kageyama. Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese population. Expert Review of Anticancer Therapy 2023; 23(5): 461 doi: 10.1080/14737140.2023.2200170
|
| 4 |
Hao Xu, Qi Liu. Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors. OncoTargets and Therapy 2021; : 13345 doi: 10.2147/OTT.S279998
|
| 5 |
Xuehui Jiang, Fangfang Xiong, Qun Fu, Hongwei Peng, Yan Jing, Kaisaner Rexiti, Xiaohua Wei, Song Tao. Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis. International Journal of Colorectal Disease 2022; 37(7): 1525 doi: 10.1007/s00384-022-04214-7
|
| 6 |
Jennifer S. Downs, David E. Gyorki. Perioperative Care of the Cancer Patient. 2023; : 343 doi: 10.1016/B978-0-323-69584-8.00030-X
|
| 7 |
Alan L. Myers, Sudarat Kiat-amnuay, Bing-Yan Wang. Effect of imatinib on oral wound healing after extraction. The Journal of the American Dental Association 2022; 153(8): 805 doi: 10.1016/j.adaj.2022.03.009
|
| 8 |
Michał Miner, Michał Elbaum, Aleksandra Jawiarczyk-Przybyłowska, Eliza Kubicka. Endokrynologiczne powikłania nowych terapii przeciwnowotworowych. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 191 doi: 10.5604/01.3001.0014.8121
|
| 9 |
Jian Wang, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Zhaolun Cai, Lin Pu, Wei Fu, Yaxuan Wang, Bo Zhang. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors. Medicine 2020; 99(9): e19275 doi: 10.1097/MD.0000000000019275
|